Centre for Community Medicine (CCM), 28730All India Institute of Medical Sciences (AIIMS), New Delhi, India.
28604Indian Council of Medical Research (ICMR), New Delhi, India.
Food Nutr Bull. 2020 Dec;41(4):438-445. doi: 10.1177/0379572120952306. Epub 2020 Sep 4.
Undernutrition is a leading risk factor for tuberculosis and is associated with adverse treatment outcomes. Energy-dense nutritional supplement (EDNS) may be helpful in managing undernutrition in tuberculosis patients.
A longitudinal study was conducted among 102 newly diagnosed pulmonary tuberculosis patients in the Ballabgarh tuberculosis unit in Haryana, India, between September 2018 and February 2019. Participants were provided daily supplementation with 2 sachets of peanut-based EDNS providing 1000 kcal along with the tuberculosis chemotherapy for 2 months. Acceptability was assessed after one month of supplementation. Reported side effects were assessed every 15 days for 2 months and adherence, in terms of proportion of supplement consumed, was assessed on weekly basis for 2 months. Weight was measured at baseline and after 1 month and 2 months.
Mean age of participants was 33 years (standard deviation: 13.8) and 75.5% of the participants were male. Almost 100% of the participants found the taste, smell, consistency, and color of the EDNS acceptable. Three participants rejected it after one month of consuming EDNS and another 7 rejected after 2 months of consuming EDNS. After consuming EDNS for 2 months, 13.9% of the participants complained of nausea, 11.9% complained of vomiting, 10.9% complained of diarrhea, and 9.9% complained of pain in the abdomen and abdominal fullness or bloating anytime during the period of supplementation. The adherence to EDNS among the participants was reported as 92.6%.
A peanut-based EDNS was highly acceptable and safe, and the adherence to it was high among patients with pulmonary tuberculosis.
营养不良是结核病的一个主要危险因素,与不良治疗结果有关。能量密集型营养补充剂(EDNS)可能有助于管理结核病患者的营养不良。
在印度哈里亚纳邦巴拉尔加赫结核病单位,对 102 例新诊断的肺结核患者进行了一项纵向研究,研究时间为 2018 年 9 月至 2019 年 2 月。参与者每天接受 2 包花生基 EDNS 补充剂,补充 1000 千卡热量,同时接受结核病化疗 2 个月。在补充一个月后评估可接受性。在接下来的 2 个月内,每 15 天评估一次报告的副作用,在接下来的 2 个月内每周评估一次补充剂的使用比例(即摄入量)。在基线和第 1 个月和第 2 个月测量体重。
参与者的平均年龄为 33 岁(标准差:13.8),其中 75.5%为男性。几乎所有参与者都认为 EDNS 的味道、气味、稠度和颜色都可以接受。有 3 名参与者在食用 EDNS 一个月后拒绝食用,另外 7 名参与者在食用 EDNS 两个月后拒绝食用。在食用 EDNS 2 个月后,13.9%的参与者出现恶心,11.9%的参与者出现呕吐,10.9%的参与者出现腹泻,9.9%的参与者在补充期间任何时候都出现腹痛、腹部饱胀或腹胀。参与者对 EDNS 的依从性报告为 92.6%。
花生基 EDNS 非常可接受且安全,肺结核患者的依从性很高。